Physician profile
Miada Saad
NPI 1851768717
$4,631.90
in general payments reported to CMS, 2019-2025
16 companies · $941 in 2025
The $941 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $647 · 2023: $1,324 · 2024: $1,421 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,566 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,565.80 |
| Education | $119.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $908.66 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $872.68 | 2021-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $732.29 | 2021-2024 | Andexxa, Farxiga |
| Boston Scientific Corporation | $560.25 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Emblem Mri S-Icd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $557.34 | 2023-2025 | Jardiance |
| Altathera Pharmaceuticals LLC | $177.62 | 2025 | Sotalol Hydrochloride |
| Edwards Lifesciences Corporation | $174.00 | 2024 | Hemosphere |
| Lexicon Pharmaceuticals, INC. | $134.23 | 2024 | Inpefa |
| Tactile Systems Technology INC | $119.09 | 2024 | Entre Plus, Flexitouch Plus |
| Recor Medical INC | $118.17 | 2024 | Paradise Renal Denervation System |
| Novo Nordisk INC | $104.67 | 2022 | |
| Merck Sharp & Dohme LLC | $66.56 | 2023 | Verquvo |
| Abbott Laboratories | $47.76 | 2023 | Ensite |
| Medtronic, INC. | $29.28 | 2023 | Micra |
| Sanofi-Aventis U.S. LLC | $15.05 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miada Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.